341
Participants
Start Date
December 31, 2012
Primary Completion Date
November 30, 2013
Study Completion Date
December 31, 2013
SEP-225289
SEP-225289 4mg once daily
SEP-225289
SEP-225289 8mg once daily
Placebo
Placebo once daily
Brooklyn Medical Institutes, LLC, Brooklyn
Suburban Research Associates, Media
CRI Lifetree, Philadelphia
NeuroScience, Inc, Herndon
Duke Child and Family Study Center, Durham
iResearch Atlanta, LLC, Decatur
Atlanta Center for Medical Research, Atlanta
Clinical Neuroscience Solutions Inc., Jacksonville
Florida Research Center, Maitland
Medical Research Group of Central Florida, Sanford
Miami Research Associates, Miami
Research Centers of America, LLC, Oakland Park
Florida Clinical Research Center, LLC, Bradenton
Clinical Neuroscience Solutions, Memphis
Midwest Clinical Research Center, Dayton
Goldpoint Clinical Research, Indianapolis
Rochester Center for Behavioral Health, Rochester Hills
Midwest Research Group, Saint Charles
IPS Research Company, Oklahoma City
Future Search Clinical Trials, LP, Austine
Pharmacology Research Institute, Los Alamitos
Pharmacology Research Institute, Encino
Excell Research, Inc, Oceanside
University of California at Irvine, Irvine
Collaborative Neuroscience Network Inc, Garden Grove
Neuropsychiatric Research Center of Orange County, Santa Ana
Oregon Center for Clinical Investigations, Inc., Portland
Eastside Therapeutic Resource, Kirkland
Summit Research Network, LLC-Seattle, Seattle
Pharmacology Research Institute, Newport Beach
Center for Emotional Fitness, Cherry Hill
Sumitomo Pharma America, Inc.
INDUSTRY